Icahn School of Medicine at Mount Sinai
1425 Madison Avenue, L14-52A
New York
NY
10029
United States
Tel: 917742-8019
29 articles about Icahn School of Medicine at Mount Sinai
-
Researchers with the Icahn School of Medicine at Mount Sinai in New York have had promising results with a cancer vaccine in an early-stage clinical trial. They published their work in the journal Nature Medicine.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Mount Sinai and USC Researchers Develop Prostate Cancer Prediction Tool That Has Unmatched Accuracy
2/7/2019
Current tools used to predict prostate cancer progression are generally subjective in nature, leading to differing interpretations among clinicians
-
December 21 Research Roundup: HIV Vaccine, Super-Accurate Cervical Cancer Test, Molecular Mechani...
12/21/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Can-Fite Enters Into Collaboration Agreement to Explore Namodenoson’s Anti-NASH Effect With Icahn School of Medicine at Mount Sinai in NYC
12/10/2018
Can-Fite to Support Research Directed by Scott Friedman, M.D. on Namodenoson in Human Liver Cells
-
New Hope for Drug Discovery in Schizophrenia, Other Diseases With Improved Screening Models
10/25/2018
Proof-of-concept study indicates utility of patient-derived cells for evaluating drug response
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
ShangPharma Innovation and Icahn School of Medicine at Mount Sinai Forge Translational Research Collaboration
1/16/2018
Under the terms of the agreement, ShangPharma Innovation will provide funding and preclinical research support to further ISMMS's objectives of validating drug targets and establishing programs to discover new therapies.
-
Goldfinch Bio Announces Collaborations with Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to Augment World's Largest Genomic Registry of Patients with Kidney Disease
10/17/2017
Goldfinch Bio today announced collaborations with the Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to generate genomic data on over 1,500 patients with proteinuric kidney disease.